This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Exosomes Europe
5-6 June 2024
DoubleTree Tower of London
Book Now
Menu
Book
Key Sessions
Bruce Werber
Regenerative Medicine: Making the Impossible Possible
BioXtek LLC Regenerative Therapeutics
Kuniko Kadoya
Fibroblast Derived Exosomes are Key Component of Skin Rejuvenation
Allergan Aesthetics/AbbVie
keyboard_arrow_right

Day One - IT (Irish Time, GMTZ)

search

Day One - IT (Irish Time, GMTZ)

search
Showing 1 of 1 Streams
08:00 - 08:55
Welcome Coffee and Registration
08:55 - 09:00
Chair’s Welcome Remarks
  • Phillip Maderia - Site Head, Lonza Lexington, Lonza
09:00 - 09:30
Finding the Right MSC for EV Therapeutics
  • Dave Mentlak - Senior Scientist, Mesenbio
09:30 - 10:00
Engineered Extracellular Vesicles for the Treatment of Immunologically "Cold" Colorectal Cancers
  • Gianluca Roma - CEO, EV Therapeutics
10:00 - 10:45
Extracellular Vesicles: Accelerating the Path from Benchtop to IND & Beyond
  • Davide Zocco - Director Site Management Lonza Siena, Lonza
  • Phillip Maderia - Site Head, Lonza Lexington, Lonza
10:45 - 11:30
Morning Break
11:30 - 12:00
Industrial Purification of Milk Derived Extracellular Vesicles
  • Spencer Marsh - Chief Scientific Officer, Tiny Cargo Company
12:00 - 12:30
Regenerative Medicine: Making the Impossible Possible
  • Bruce Werber - CEO, BioXtek LLC Regenerative Therapeutics
12:30 - 13:00
Clinical Scale Production of Extracellular Vesicles in a closed, 3-D Perfusion Hollow Fiber Bioreactor
  • John Cadwell - President and CEO, FiberCell Systems Inc.
13:00 - 14:30
Exhibition Hall and Lunch
14:30 - 15:00
Fibroblast Derived Exosomes are Key Component of Skin Rejuvenation
  • Kuniko Kadoya - Director / Research Fellow, Allergan Aesthetics/AbbVie
15:00 - 15:30
Extracellular Vesicles for Oral Delivery of Biologics
  • Driton Vllasaliu - Senior Lecturer in Pharmaceutics, Kings College London
15:30 - 16:00
Development of an Amniotic Fluid Derived Stem Cell Secretome as a Cell Free Therapeutic for Necrotising Enterocolitis
  • Steve Ray - Chief Scientific Officer, Micregen Ltd.
16:00 - 17:00
Drinks Reception
NextDay Two
Choose Day